AXON: Record Q3 revenue and faster software growth, offset by delayed Federal Dedrone deployments

What happened

Axon reported record third-quarter revenue of $909 million, up 28%, and said growth in its Software & Services business accelerated while adjusted EBITDA, a measure of operating earnings, rose 33%. It lowered its full-year revenue growth guidance to about 30% after roughly $130 million of Federal Dedrone deployments shifted out of 2026.

Confirmed

Global impact / market context

The delayed deployments reduce revenue expected in the period covered by Axon’s updated outlook, even as its reported quarterly growth remained strong. If federal customers deploy the systems later, revenue may move between reporting periods; the article does not say the deployments were canceled or quantify any cost effect.

Analyst inference

The update combines strong reported results with weaker near-term growth guidance, so investors may weigh software momentum against the timing of federal deployments. Because the article gives no share-price reaction, profit forecast beyond adjusted EBITDA growth, or revised deployment schedule, the net effect on valuation is unclear.

Analyst inference

What to watch

1. Watch Axon’s next revenue guidance and reported growth to see whether the lower full-year outlook persists or reflects mainly the shifted timing of federal deployments. Analyst inference
2. Look for company updates on when the roughly $130 million of Federal Dedrone deployments are expected to occur; the article provides no replacement schedule. Analyst inference
3. Track Software & Services growth and adjusted EBITDA in later results to assess whether the quarterly acceleration and earnings growth continue alongside delayed federal deployments. Analyst inference

Evidence

• Original source link unavailable